Means and methods for counteracting myeloproliferative or lymphoproliferative disorders

The invention provides human AML-specific binding compounds that are able to bind a cell surface component of AML cells. Therapeutic uses of binding compounds against AML are also provided.

Saved in:
Bibliographic Details
Main Authors Kedde, Martijn, Bakker, Adrianus Quirinus, Hazenberg, Mette Deborah, Spits, Hergen, Gillissen, Marijn Aletta, Beaumont, Tim
Format Patent
LanguageEnglish
Published 18.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides human AML-specific binding compounds that are able to bind a cell surface component of AML cells. Therapeutic uses of binding compounds against AML are also provided.
Bibliography:Application Number: AU20140367398